Drug Controller General of India (DCGI) has given approval to Zydus Cadila for clinical trial of the Company’s anti-diabetic molecule.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
TopNews runs with your support. Please send your suggestions / comments to editor at topnews.us